Preclinical Cell and Gene Therapy Research
For cell and gene therapy programs requiring controlled in vivo studies, the contract vivarium model provides a stable research environment with integrated operational support.
Choose a LocationEnabling Innovation in Cell and Gene Therapy Research
Built for the complex demands of cell and gene therapy development, Mispro provides controlled, compliant contract vivarium environments with integrated husbandry, veterinary care, and regulatory oversight services. Scientists maintain direct control of study design and execution while generating reproducible in vivo data that informs early development decisions in genome editing, viral vector delivery, and advanced therapeutic platforms.
Across our network of AAALAC-accredited contract vivarium facilities, biotech teams can conduct non-GLP rodent studies supporting target validation, vector performance, gene editing outcomes, and therapeutic response.
Contract Vivarium Lab Space for CGT Research
Emerging and established biotech and biopharma teams advancing cell therapies, gene therapies, and genome editing technologies benefit from controlled in vivo research environments that support complex experimental designs and parallel study workflows. Mispro’s contract vivarium model provides research-ready vivarium space with integrated animal care and regulatory support, allowing scientists to maintain direct oversight of CGT studies within a professionally managed setting.
Stable Environments for In Vivo Cell & Gene Therapy Research
Mispro's contract vivarium facilities provide a turnkey option for preclinical R&D that keeps studies in-house and in the hands of founding scientists.
Whether your company is pioneering a new drug, is on the forefront of cell and gene therapy, or has a team of scientists pursuing platform targets, Mispro is an optimal environment for your in vivo drug development research.
Cell and Gene Therapy Research Areas Supported
Mispro’s contract vivarium environments support preclinical in vivo research across a wide range of cell and gene therapy development programs, including:
Innovation Across Our Network
- 88% Novel / Proprietary Research
- 58% Translational Programs
- 46% Platform Companies
Mispro vs. CRO
- 6X Increase in study throughput
- 50% Less spend over time
- 70% Reduction in failure rates
Where Cutting-Edge Therapies Meet Expert Animal Care
We provide the controlled environments and expert oversight your cell and gene therapy models require.